Clinical Trial Update: TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes TherVacB, a heterologous protein prime/MVA boost therapeutic vaccine candidate for chronic hepatitis B, currently in Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TherVacB

Snippet

Sponsor: Michael Hoelscher | Conditions: Chronic Hepatitis B | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION